Now On-Demand: Thomas Ahlering, MD, performs a Robot Assisted Radical Prostatectomy (RARP). This ORLive Signature Series broadcast was originally streamed LIVED on 1/29/2019.
Performing Doctor: Thomas Ahlering, MD
One in six American men will be diagnosed with prostate cancer within their lifetime. Approximately 27,000 men die annually due to prostate cancer, making it the second most fatal cancer in men. Ten-year disease specific survival rates of patients with a robotic prostatectomy are greater than 90%. The Department of Urology at the UC Irvine Medical Center was one of the first institutions to offer robotic prostatectomy using the da Vinci Robotic Slave Interface. This groundbreaking technology, listed as number one in Forbes Magazine's "Five Robots That Will Change Your Life," provides unprecedented 3-D vision and precise robotic instrument manipulation.
Case Details: Patient MV is 65 years old, recently diagnosed with prostate cancer, GS4+3. PSA history is between 8 and 11 in the last three years. 5/6 cores positive on the left with GS 3+3 small volume disease; 3/9 cores positive on the right midlateral GS 4+3 cancer, plus a positive biopsy for GS4+3 cancer in a MRI targeted lesion in the R midgland and base. Prostate volume is 66gm on MRI. AUASS is 0 and SHIM is 25; patient is quite concerned about loss of sexual function due to surgery.
Dr. Ahlering will be performing a bilateral nerve-sparing robot-assisted radical prostatectomy with possible right or left side inguinal hernia repair with mesh. There will be no pelvic lymph node dissection.